Danone (ENXTPA:BN) has reaffirmed its 2026 outlook, maintaining a like-for-like sales growth target of 3% to 5%, with recurring operating income projected to rise at a quicker pace than revenue.
That guidance sits against a mixed trading backdrop, with the share price at €67.12 after a 14.19% one-month share price gain, yet still down 11.73% year to date. The 3-year total shareholder return of 29.12% points to stronger longer-run momentum.
Compare Danone's reaffirmed outlook with other consumer-focused companies by scanning our hand-picked 224 high quality undervalued stocks that combine quality fundamentals with potential mispricing.
The recent jump in Danone’s share price, alongside reaffirmed guidance, could signal improving conviction in the underlying business rather than a short burst of optimism. How does that align with where the valuation sits today?
Most Popular Narrative: 15% Undervalued
On the most followed narrative, Danone’s fair value of €78.52 compares to a last close of €67.12, which points to a discount that depends on how well its premium nutrition and specialty products keep delivering.
The main requirement for success is effective execution of the multi-engine growth model, with high-protein and medical nutrition platforms, emerging markets IMF and new M&A all contributing without major disruption from recalls, capacity constraints or geopolitical events.
See why 31 investors see Danone as 15% undervalued.
Result: Fair Value of €78.52 (UNDERVALUED)
Still, the narrative can crack if the North America yogurt turnaround stalls, or if further recalls and regional disruptions hit Danone’s margins and cash generation.
Find out about the key risks to this Danone narrative.
Next Steps
Mixed signals on Danone can be confusing, so it helps to look directly at the underlying data and decide how the risk and reward balance feels to you. To weigh both sides in one place, review the 4 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Danone?
If Danone has sharpened your focus on quality, do not stop here. Fresh opportunities often sit just outside the obvious names you already follow.
- Target resilient compounding potential by scanning companies with strong cash positions and low leverage using our list of solid balance sheet and fundamentals (193 results).
- Hunt for mispriced quality by filtering for businesses with robust fundamentals that still trade at appealing valuations through the 224 high quality undervalued stocks.
- Build a cash flow focused plan by zeroing in on income ideas screened using the 232 dividend fortresses.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com